« Previous
Next »
Atherosclerosis
Volume 205, Issue 1
, Pages 239-243
, July 2009
Myeloperoxidase overexpression in children with hypercholesterolemia
References
- . Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999;354:1234–1241
- Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis, The Bogalusa Heart Study. N Engl J Med. 1986;314:138–144
- . Effects of serum lipoproteins and smoking on atherosclerosis in young men and women, The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 1997;17:95–106
- Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:2277–2283
- . Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J Cardiol. 2006;98:9P–17P
- Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia potential role of NADPH oxidase. Pediatrics. 2008;122:e648–e655
- . Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr Med Chem. 2007;14:339–351
- . Urinary F2-isoprostanes in young healthy children at risk for type 1 diabetes mellitus. Free Radic Biol Med. 2003;35:551–557
- . Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med. 2000;28:1717–1725
- Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. Atherosclerosis. 2008;196:356–364
- . Growth at adolescence. The development of the reproductive system. 2nd ed.. Oxford, United Kingdom: Blackwell; 1962;pp. 28–39
- Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J Am Coll Cardiol. 2007;49:1974–1981
- . Serious infections in children: an incidence study in family practice. BMC Fam Pract. 2006;7:23
- . Reexamination of the relationship of resting metabolic rate to fat-free mass and to the metabolically active components of fat-free mass in humans. Am J Clin Nutr. 1992;55:790–794
- Macrophage scavenger receptor CD36 is the major receptor for LDL modified monocyte-generated reactive nitrogen species. J Clin Invest. 2000;105:1095–1108
- . Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture bymyeloperoxidase. J Biol Chem. 2001;276:41279–41287
- . Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem. 2000;275:37524–37532
- Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science. 2002;296:2391–2394
- . Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286:2136–2142
- Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349:1595–1604
- CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440–1445
- Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin. J Thromb Haemost. 2007;5:1170–1178
- Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet. 2001;9:780–786
☆ This study was supported in part by a grant from the “La Sapienza” University of Rome (Ateneo 2006) to FV.
PII: S0021-9150(08)00764-8
doi: 10.1016/j.atherosclerosis.2008.10.025
© 2008 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Atherosclerosis
Volume 205, Issue 1
, Pages 239-243
, July 2009
